Inositols: from established knowledge to novel approaches

Autores
Dinicola, Simona; Unfer, Vittorio; Facchinetti, Fabio; Soulage, Christophe O.; Greene, Nicholas D.; Bizzarri, Mariano; Laganà, Antonio Simone; Chan, Shiao Yng; Bevilacqua, Arturo; Pkhaladze, Lali; Benvenga, Salvatore; Stringaro, Annarita; Barbaro, Daniele; Appetecchia, Marialuisa; Aragona, Cesare; Espinola, Maria Salomè Bezerra; Cantelmi, Tonino; Cavalli, Pietro; Chiu, Tony T.; Copp, Andrew J.; D'Anna, Rosario; Dewailly, Didier; di Lorenzo, Cherubino; Diamanti Kandarakis, Evanthia; Marín, Imelda Hernández; Hod, Moshe; Kamenov, Zdravko; Kandaraki, Eleni; Monastra, Giovanni; Oliva, Mario Montanino; Nestler, John E.; Nordio, Maurizio; Ozay, Ali C.; Papalou, Olga; Porcaro, Giuseppina; Prapas, Nikos; Roseff, Scott; Vazquez, Monica Hebe; Vucenik, Ivana; Wdowiak, Artur
Año de publicación
2021
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects.
Fil: Dinicola, Simona. Sapienza Università di Roma. System Biology Group Lab; Italia
Fil: Unfer, Vittorio. Università di Modena e Reggio Emilia; Italia
Fil: Facchinetti, Fabio. Università di Modena e Reggio Emilia; Italia
Fil: Soulage, Christophe O.. Inserm; Francia
Fil: Greene, Nicholas D.. University College London; Estados Unidos
Fil: Bizzarri, Mariano. Sapienza Università di Roma. System Biology Group Lab; Italia. Università degli Studi di Roma "La Sapienza"; Italia
Fil: Laganà, Antonio Simone. Università degli Studi dell’Insubria. Ospedale Filippo del Ponte; Italia
Fil: Chan, Shiao Yng. National University of Singapore; Singapur
Fil: Bevilacqua, Arturo. Università degli Studi di Roma "La Sapienza"; Italia
Fil: Pkhaladze, Lali. Zhordania and Khomasuridze Institute of Reproductology; Georgia
Fil: Benvenga, Salvatore. Università degli Studi di Messina; Italia
Fil: Stringaro, Annarita. Istituto Superiore di Sanita; Italia
Fil: Barbaro, Daniele. Ospedale Civile Di Livorno; Italia
Fil: Appetecchia, Marialuisa. Regina Elena National Cancer Institute; Italia
Fil: Aragona, Cesare. Sapienza Università di Roma. System Biology Group Lab; Italia
Fil: Espinola, Maria Salomè Bezerra. Sapienza Università di Roma. System Biology Group Lab; Italia
Fil: Cantelmi, Tonino. Institute For Interpersonal Cognitive Therapy; Italia
Fil: Cavalli, Pietro. Humanitas Research Hospital; Italia
Fil: Chiu, Tony T.. IVF Centre; China
Fil: Copp, Andrew J.. University College London; Estados Unidos
Fil: D'Anna, Rosario. Università degli Studi di Messina; Italia
Fil: Dewailly, Didier. Université de Lille; Francia
Fil: di Lorenzo, Cherubino. Università degli studi di Roma "La Sapienza"; Italia
Fil: Diamanti Kandarakis, Evanthia. Hygeia Hospital; Grecia
Fil: Marín, Imelda Hernández. Universidad Nacional Autónoma de México; México
Fil: Hod, Moshe. Universitat Tel Aviv; Israel
Fil: Kamenov, Zdravko. Sofia University St. Kliment Ohridski; Bulgaria
Fil: Kandaraki, Eleni. Hygeia Hospital; Grecia
Fil: Monastra, Giovanni. Systems Biology Group Lab; Italia
Fil: Oliva, Mario Montanino. Sofia University St. Kliment Ohridski; Bulgaria
Fil: Nestler, John E.. Virginia Commonwealth University; Estados Unidos
Fil: Nordio, Maurizio. Azienda Sanitaria Locale Roma ; Italia
Fil: Ozay, Ali C.. Near East University Hospital; Chipre
Fil: Papalou, Olga. Hygeia Hospital; Grecia
Fil: Porcaro, Giuseppina. Azienda USL UMBRIA ; Italia
Fil: Prapas, Nikos. Iakentro; Grecia
Fil: Roseff, Scott. South Florida Institute for Reproductive Medicine; Estados Unidos
Fil: Vazquez, Monica Hebe. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Vucenik, Ivana. University of Maryland; Estados Unidos
Fil: Wdowiak, Artur. Medical University Of Lublin (medical University Of Lublin);
Materia
AROMATASE
D-CHIRO-INOSITOL
EPIMERASE
FSH
GDM
MYO-INOSITOL
NEURAL TUBE DEFECTS
PCOS
STEROIDOGENESIS
TESTOSTERONE
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/203888

id CONICETDig_f0efa61993e4c1ed8e4bbfebb6d8d9ba
oai_identifier_str oai:ri.conicet.gov.ar:11336/203888
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Inositols: from established knowledge to novel approachesDinicola, SimonaUnfer, VittorioFacchinetti, FabioSoulage, Christophe O.Greene, Nicholas D.Bizzarri, MarianoLaganà, Antonio SimoneChan, Shiao YngBevilacqua, ArturoPkhaladze, LaliBenvenga, SalvatoreStringaro, AnnaritaBarbaro, DanieleAppetecchia, MarialuisaAragona, CesareEspinola, Maria Salomè BezerraCantelmi, ToninoCavalli, PietroChiu, Tony T.Copp, Andrew J.D'Anna, RosarioDewailly, Didierdi Lorenzo, CherubinoDiamanti Kandarakis, EvanthiaMarín, Imelda HernándezHod, MosheKamenov, ZdravkoKandaraki, EleniMonastra, GiovanniOliva, Mario MontaninoNestler, John E.Nordio, MaurizioOzay, Ali C.Papalou, OlgaPorcaro, GiuseppinaPrapas, NikosRoseff, ScottVazquez, Monica HebeVucenik, IvanaWdowiak, ArturAROMATASED-CHIRO-INOSITOLEPIMERASEFSHGDMMYO-INOSITOLNEURAL TUBE DEFECTSPCOSSTEROIDOGENESISTESTOSTERONEhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects.Fil: Dinicola, Simona. Sapienza Università di Roma. System Biology Group Lab; ItaliaFil: Unfer, Vittorio. Università di Modena e Reggio Emilia; ItaliaFil: Facchinetti, Fabio. Università di Modena e Reggio Emilia; ItaliaFil: Soulage, Christophe O.. Inserm; FranciaFil: Greene, Nicholas D.. University College London; Estados UnidosFil: Bizzarri, Mariano. Sapienza Università di Roma. System Biology Group Lab; Italia. Università degli Studi di Roma "La Sapienza"; ItaliaFil: Laganà, Antonio Simone. Università degli Studi dell’Insubria. Ospedale Filippo del Ponte; ItaliaFil: Chan, Shiao Yng. National University of Singapore; SingapurFil: Bevilacqua, Arturo. Università degli Studi di Roma "La Sapienza"; ItaliaFil: Pkhaladze, Lali. Zhordania and Khomasuridze Institute of Reproductology; GeorgiaFil: Benvenga, Salvatore. Università degli Studi di Messina; ItaliaFil: Stringaro, Annarita. Istituto Superiore di Sanita; ItaliaFil: Barbaro, Daniele. Ospedale Civile Di Livorno; ItaliaFil: Appetecchia, Marialuisa. Regina Elena National Cancer Institute; ItaliaFil: Aragona, Cesare. Sapienza Università di Roma. System Biology Group Lab; ItaliaFil: Espinola, Maria Salomè Bezerra. Sapienza Università di Roma. System Biology Group Lab; ItaliaFil: Cantelmi, Tonino. Institute For Interpersonal Cognitive Therapy; ItaliaFil: Cavalli, Pietro. Humanitas Research Hospital; ItaliaFil: Chiu, Tony T.. IVF Centre; ChinaFil: Copp, Andrew J.. University College London; Estados UnidosFil: D'Anna, Rosario. Università degli Studi di Messina; ItaliaFil: Dewailly, Didier. Université de Lille; FranciaFil: di Lorenzo, Cherubino. Università degli studi di Roma "La Sapienza"; ItaliaFil: Diamanti Kandarakis, Evanthia. Hygeia Hospital; GreciaFil: Marín, Imelda Hernández. Universidad Nacional Autónoma de México; MéxicoFil: Hod, Moshe. Universitat Tel Aviv; IsraelFil: Kamenov, Zdravko. Sofia University St. Kliment Ohridski; BulgariaFil: Kandaraki, Eleni. Hygeia Hospital; GreciaFil: Monastra, Giovanni. Systems Biology Group Lab; ItaliaFil: Oliva, Mario Montanino. Sofia University St. Kliment Ohridski; BulgariaFil: Nestler, John E.. Virginia Commonwealth University; Estados UnidosFil: Nordio, Maurizio. Azienda Sanitaria Locale Roma ; ItaliaFil: Ozay, Ali C.. Near East University Hospital; ChipreFil: Papalou, Olga. Hygeia Hospital; GreciaFil: Porcaro, Giuseppina. Azienda USL UMBRIA ; ItaliaFil: Prapas, Nikos. Iakentro; GreciaFil: Roseff, Scott. South Florida Institute for Reproductive Medicine; Estados UnidosFil: Vazquez, Monica Hebe. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Vucenik, Ivana. University of Maryland; Estados UnidosFil: Wdowiak, Artur. Medical University Of Lublin (medical University Of Lublin);MDPI2021-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/203888Dinicola, Simona; Unfer, Vittorio; Facchinetti, Fabio; Soulage, Christophe O.; Greene, Nicholas D.; et al.; Inositols: from established knowledge to novel approaches; MDPI; International Journal of Molecular Sciences; 22; 19; 10-2021; 1-301661-65961422-0067CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.3390/ijms221910575info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:43:37Zoai:ri.conicet.gov.ar:11336/203888instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:43:37.539CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Inositols: from established knowledge to novel approaches
title Inositols: from established knowledge to novel approaches
spellingShingle Inositols: from established knowledge to novel approaches
Dinicola, Simona
AROMATASE
D-CHIRO-INOSITOL
EPIMERASE
FSH
GDM
MYO-INOSITOL
NEURAL TUBE DEFECTS
PCOS
STEROIDOGENESIS
TESTOSTERONE
title_short Inositols: from established knowledge to novel approaches
title_full Inositols: from established knowledge to novel approaches
title_fullStr Inositols: from established knowledge to novel approaches
title_full_unstemmed Inositols: from established knowledge to novel approaches
title_sort Inositols: from established knowledge to novel approaches
dc.creator.none.fl_str_mv Dinicola, Simona
Unfer, Vittorio
Facchinetti, Fabio
Soulage, Christophe O.
Greene, Nicholas D.
Bizzarri, Mariano
Laganà, Antonio Simone
Chan, Shiao Yng
Bevilacqua, Arturo
Pkhaladze, Lali
Benvenga, Salvatore
Stringaro, Annarita
Barbaro, Daniele
Appetecchia, Marialuisa
Aragona, Cesare
Espinola, Maria Salomè Bezerra
Cantelmi, Tonino
Cavalli, Pietro
Chiu, Tony T.
Copp, Andrew J.
D'Anna, Rosario
Dewailly, Didier
di Lorenzo, Cherubino
Diamanti Kandarakis, Evanthia
Marín, Imelda Hernández
Hod, Moshe
Kamenov, Zdravko
Kandaraki, Eleni
Monastra, Giovanni
Oliva, Mario Montanino
Nestler, John E.
Nordio, Maurizio
Ozay, Ali C.
Papalou, Olga
Porcaro, Giuseppina
Prapas, Nikos
Roseff, Scott
Vazquez, Monica Hebe
Vucenik, Ivana
Wdowiak, Artur
author Dinicola, Simona
author_facet Dinicola, Simona
Unfer, Vittorio
Facchinetti, Fabio
Soulage, Christophe O.
Greene, Nicholas D.
Bizzarri, Mariano
Laganà, Antonio Simone
Chan, Shiao Yng
Bevilacqua, Arturo
Pkhaladze, Lali
Benvenga, Salvatore
Stringaro, Annarita
Barbaro, Daniele
Appetecchia, Marialuisa
Aragona, Cesare
Espinola, Maria Salomè Bezerra
Cantelmi, Tonino
Cavalli, Pietro
Chiu, Tony T.
Copp, Andrew J.
D'Anna, Rosario
Dewailly, Didier
di Lorenzo, Cherubino
Diamanti Kandarakis, Evanthia
Marín, Imelda Hernández
Hod, Moshe
Kamenov, Zdravko
Kandaraki, Eleni
Monastra, Giovanni
Oliva, Mario Montanino
Nestler, John E.
Nordio, Maurizio
Ozay, Ali C.
Papalou, Olga
Porcaro, Giuseppina
Prapas, Nikos
Roseff, Scott
Vazquez, Monica Hebe
Vucenik, Ivana
Wdowiak, Artur
author_role author
author2 Unfer, Vittorio
Facchinetti, Fabio
Soulage, Christophe O.
Greene, Nicholas D.
Bizzarri, Mariano
Laganà, Antonio Simone
Chan, Shiao Yng
Bevilacqua, Arturo
Pkhaladze, Lali
Benvenga, Salvatore
Stringaro, Annarita
Barbaro, Daniele
Appetecchia, Marialuisa
Aragona, Cesare
Espinola, Maria Salomè Bezerra
Cantelmi, Tonino
Cavalli, Pietro
Chiu, Tony T.
Copp, Andrew J.
D'Anna, Rosario
Dewailly, Didier
di Lorenzo, Cherubino
Diamanti Kandarakis, Evanthia
Marín, Imelda Hernández
Hod, Moshe
Kamenov, Zdravko
Kandaraki, Eleni
Monastra, Giovanni
Oliva, Mario Montanino
Nestler, John E.
Nordio, Maurizio
Ozay, Ali C.
Papalou, Olga
Porcaro, Giuseppina
Prapas, Nikos
Roseff, Scott
Vazquez, Monica Hebe
Vucenik, Ivana
Wdowiak, Artur
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv AROMATASE
D-CHIRO-INOSITOL
EPIMERASE
FSH
GDM
MYO-INOSITOL
NEURAL TUBE DEFECTS
PCOS
STEROIDOGENESIS
TESTOSTERONE
topic AROMATASE
D-CHIRO-INOSITOL
EPIMERASE
FSH
GDM
MYO-INOSITOL
NEURAL TUBE DEFECTS
PCOS
STEROIDOGENESIS
TESTOSTERONE
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects.
Fil: Dinicola, Simona. Sapienza Università di Roma. System Biology Group Lab; Italia
Fil: Unfer, Vittorio. Università di Modena e Reggio Emilia; Italia
Fil: Facchinetti, Fabio. Università di Modena e Reggio Emilia; Italia
Fil: Soulage, Christophe O.. Inserm; Francia
Fil: Greene, Nicholas D.. University College London; Estados Unidos
Fil: Bizzarri, Mariano. Sapienza Università di Roma. System Biology Group Lab; Italia. Università degli Studi di Roma "La Sapienza"; Italia
Fil: Laganà, Antonio Simone. Università degli Studi dell’Insubria. Ospedale Filippo del Ponte; Italia
Fil: Chan, Shiao Yng. National University of Singapore; Singapur
Fil: Bevilacqua, Arturo. Università degli Studi di Roma "La Sapienza"; Italia
Fil: Pkhaladze, Lali. Zhordania and Khomasuridze Institute of Reproductology; Georgia
Fil: Benvenga, Salvatore. Università degli Studi di Messina; Italia
Fil: Stringaro, Annarita. Istituto Superiore di Sanita; Italia
Fil: Barbaro, Daniele. Ospedale Civile Di Livorno; Italia
Fil: Appetecchia, Marialuisa. Regina Elena National Cancer Institute; Italia
Fil: Aragona, Cesare. Sapienza Università di Roma. System Biology Group Lab; Italia
Fil: Espinola, Maria Salomè Bezerra. Sapienza Università di Roma. System Biology Group Lab; Italia
Fil: Cantelmi, Tonino. Institute For Interpersonal Cognitive Therapy; Italia
Fil: Cavalli, Pietro. Humanitas Research Hospital; Italia
Fil: Chiu, Tony T.. IVF Centre; China
Fil: Copp, Andrew J.. University College London; Estados Unidos
Fil: D'Anna, Rosario. Università degli Studi di Messina; Italia
Fil: Dewailly, Didier. Université de Lille; Francia
Fil: di Lorenzo, Cherubino. Università degli studi di Roma "La Sapienza"; Italia
Fil: Diamanti Kandarakis, Evanthia. Hygeia Hospital; Grecia
Fil: Marín, Imelda Hernández. Universidad Nacional Autónoma de México; México
Fil: Hod, Moshe. Universitat Tel Aviv; Israel
Fil: Kamenov, Zdravko. Sofia University St. Kliment Ohridski; Bulgaria
Fil: Kandaraki, Eleni. Hygeia Hospital; Grecia
Fil: Monastra, Giovanni. Systems Biology Group Lab; Italia
Fil: Oliva, Mario Montanino. Sofia University St. Kliment Ohridski; Bulgaria
Fil: Nestler, John E.. Virginia Commonwealth University; Estados Unidos
Fil: Nordio, Maurizio. Azienda Sanitaria Locale Roma ; Italia
Fil: Ozay, Ali C.. Near East University Hospital; Chipre
Fil: Papalou, Olga. Hygeia Hospital; Grecia
Fil: Porcaro, Giuseppina. Azienda USL UMBRIA ; Italia
Fil: Prapas, Nikos. Iakentro; Grecia
Fil: Roseff, Scott. South Florida Institute for Reproductive Medicine; Estados Unidos
Fil: Vazquez, Monica Hebe. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Vucenik, Ivana. University of Maryland; Estados Unidos
Fil: Wdowiak, Artur. Medical University Of Lublin (medical University Of Lublin);
description Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to clinical approaches in ameliorating many gynecological and endocrinological diseases. Currently both myo-Ins and D-chiro-Ins are well-tolerated, effective alternative candidates to the classical insulin sensitizers, and are useful treatments in preventing and treating metabolic and reproductive disorders such as polycystic ovary syndrome (PCOS), gestational diabetes mellitus (GDM), and male fertility disturbances, like sperm abnormalities. Moreover, besides metabolic activity, myo-Ins and D-chiro-Ins deeply influence steroidogenesis, regulating the pools of androgens and estrogens, likely in opposite ways. Given the complexity of inositol-related mechanisms of action, many of their beneficial effects are still under scrutiny. Therefore, continuing research aims to discover new emerging roles and mechanisms that can allow clinicians to tailor inositol therapy and to use it in other medical areas, hitherto unexplored. The present paper outlines the established evidence on inositols and updates on recent research, namely concerning D-chiro-Ins involvement into steroidogenesis. In particular, D-chiro-Ins mediates insulin-induced testosterone biosynthesis from ovarian thecal cells and directly affects synthesis of estrogens by modulating the expression of the aromatase enzyme. Ovaries, as well as other organs and tissues, are characterized by a specific ratio of myo-Ins to D-chiro-Ins, which ensures their healthy state and proper functionality. Altered inositol ratios may account for pathological conditions, causing an imbalance in sex hormones. Such situations usually occur in association with medical conditions, such as PCOS, or as a consequence of some pharmacological treatments. Based on the physiological role of inositols and the pathological implications of altered myo-Ins to D-chiro-Ins ratios, inositol therapy may be designed with two different aims: (1) restoring the inositol physiological ratio; (2) altering the ratio in a controlled way to achieve specific effects.
publishDate 2021
dc.date.none.fl_str_mv 2021-10
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/203888
Dinicola, Simona; Unfer, Vittorio; Facchinetti, Fabio; Soulage, Christophe O.; Greene, Nicholas D.; et al.; Inositols: from established knowledge to novel approaches; MDPI; International Journal of Molecular Sciences; 22; 19; 10-2021; 1-30
1661-6596
1422-0067
CONICET Digital
CONICET
url http://hdl.handle.net/11336/203888
identifier_str_mv Dinicola, Simona; Unfer, Vittorio; Facchinetti, Fabio; Soulage, Christophe O.; Greene, Nicholas D.; et al.; Inositols: from established knowledge to novel approaches; MDPI; International Journal of Molecular Sciences; 22; 19; 10-2021; 1-30
1661-6596
1422-0067
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.3390/ijms221910575
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268613871927296
score 13.13397